Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Clinical trial NCT00617929 · TERMINATED
Trial details
- NCT number
- NCT00617929
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2014-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.